Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$16,043,610
in 4 filings, $16.0M under 10b5-1 plans

Net −$16,043,610. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Savitz Ryan −$11.2M EVP, CFO & CBO sold 100% of stake
  2. Randhawa Simrat −$2.5M EVP, Head of R&D sold 85% of stake
  3. CARR EDWARD −$2.0M CHIEF ACCOUNTING OFFICER sold 100% of stake
  4. Read Simon −$327K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2020-06-05 Scadden David Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-06-05 Albers Jeffrey W. Director Grant or award · Stock Option (Right to Buy) +18,188 18,188
2020-04-14 DAVIS JOHN C. JR See Remarks Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-02-10 DAVIS JOHN C. JR Chief Medical Officer Grant or award · Stock Option (Right to Buy) +104,000 104,000
2020-02-10 Ryan Jason See Remarks Grant or award · Stock Option (Right to Buy) +75,000 75,000
2020-02-10 ISACSON CHRISTINA K. Chief Business Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-02-10 ZDRAVESKI ZORAN See Remarks Grant or award · Stock Option (Right to Buy) +60,000 60,000
2020-02-10 GARDNER JASON See Remarks Grant or award · Stock Option (Right to Buy) +275,000 275,000
2020-01-10 GARDNER JASON See Remarks Sale −11,200 $15.25 $171K 251,212
2020-01-02 DAVIS JOHN C. JR Chief Medical Officer Option exercise +11,294 $9.49 $107K 19,598
2020-01-02 DAVIS JOHN C. JR Chief Medical Officer Sale −11,294 $15.04 $170K 8,304
2020-01-02 DAVIS JOHN C. JR Chief Medical Officer Option exercise · Stock Option (Right to Buy) −11,294 224,831
2020-01-02 GARDNER JASON See Remarks Sale −2,800 $15.10 $42K 262,412
2019-12-24 ZDRAVESKI ZORAN See Remarks Option exercise +820 $7.71 $6K 140,912
2019-12-24 ZDRAVESKI ZORAN See Remarks Sale −7,902 $16.00 $126K 133,010
2019-12-24 ZDRAVESKI ZORAN See Remarks Option exercise · Stock Option (Right to Buy) −820 16,856
2019-12-24 ISACSON CHRISTINA K. Chief Business Officer Sale −4,463 $16.01 $71K 83,786
2019-12-24 ZDRAVESKI ZORAN See Remarks Sale −7,902 $16.00 $126K 128,009
2019-12-23 ZDRAVESKI ZORAN See Remarks Option exercise +9 $7.71 $69 140,101
2019-12-23 ZDRAVESKI ZORAN See Remarks Option exercise +4,172 $9.49 $40K 144,273

Page 18 of 24 · 470 trades